These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 19099914)
1. [Ceftriaxone-associated pseudolithiasis in children]. Zhang L; Yao Y Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):877-8. PubMed ID: 19099914 [No Abstract] [Full Text] [Related]
2. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children. Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-induced pseudolithiasis: not just a theoretical risk. Fan L; Lau P; Kapur J; Karthik SV Singapore Med J; 2017 Nov; 58(11):676-677. PubMed ID: 29167906 [No Abstract] [Full Text] [Related]
6. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Prince JS; Senac MO Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336 [TBL] [Abstract][Full Text] [Related]
7. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases]. Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960 [TBL] [Abstract][Full Text] [Related]
9. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report. Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101 [TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-associated nephrolithiasis. Grasberger H; Otto B; Loeschke K Ann Pharmacother; 2000 Sep; 34(9):1076-7. PubMed ID: 10981257 [No Abstract] [Full Text] [Related]
11. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases. Araz N; Okan V; Demirci M; Araz M Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554 [TBL] [Abstract][Full Text] [Related]
12. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults. Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369 [TBL] [Abstract][Full Text] [Related]
13. [Gallstones in association with the use of ceftriaxone in children]. Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541 [TBL] [Abstract][Full Text] [Related]
14. [Ceftriaxone-associated biliary pseudolithiasis in a child]. Wang YQ Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712 [No Abstract] [Full Text] [Related]
18. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Blais C; Duperval R Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805 [TBL] [Abstract][Full Text] [Related]
19. Clinical pharmaceutics and calcium-ceftriaxone. Gin AS; Wheaton H; Dalton B Ann Pharmacother; 2008 Mar; 42(3):450-1. PubMed ID: 18230702 [No Abstract] [Full Text] [Related]
20. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome]. Zheng FY; Xing Y; Lu S; Liu DM Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889 [No Abstract] [Full Text] [Related] [Next] [New Search]